@article{TLCR20391,
author = {Shin-Kyo Yoon and Chang Min Choi and Jae Cheol Lee},
title = {The continued EGFR-TKI with cytotoxic chemotherapy at progression—poison or medicine?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {EGFR tyrosine kinase inhibitors (TKI) have shown the efficacy in treatment of lung cancer patients with EGFR sensitizing mutations, and their use has led to a doubling of progression-free survival (PFS) and a lengthening of overall survival (OS) by more than 2 years.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/20391}
}